武汉云克隆科技股份有限公司

前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体(生物素标记)

Biotin-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9

  • 前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体(生物素标记)产品包装(模拟)
  • 前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体(生物素标记)产品包装(模拟)
  • 前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体(生物素标记)DAB staining on IHC-P;
    Samples: Human Colorectal cancer Tissue
    Primary Ab: 20µg/ml Biotin-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
    Second Ab: 2µg/ml HRP-Labeled Streptavidin (Catalog: IS089)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对PCSK9的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别PCSK9。

用法

免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPE189Hu02前蛋白转化酶枯草溶菌素9(PCSK9)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPE189Hu01前蛋白转化酶枯草溶菌素9(PCSK9)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAE189Hu02前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体WB; IHC; ICC; IP.
PAE189Hu01前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体WB; IHC; ICC; IP.
LAE189Hu71前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体(生物素标记)WB; IHC; ICC.
SEE189Hu前蛋白转化酶枯草溶菌素9(PCSK9)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
AEE189Hu抗前蛋白转化酶枯草溶菌素9抗体(Anti-PCSK9)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antibody Detection.
LME189Hu前蛋白转化酶枯草溶菌素9(PCSK9)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Biological Trace Element ResearchSynergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers[pubmed:28409410]
BASIC RESEARCH IN CARDIOLOGYAutocrine effects of PCSK9 on cardiomyocytes[Pubmed: 33169229]
J Transl MedMulti-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans[33407555]
MetabolismMiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice[33775647]
Eur Rev Med Pharmacol SciAssociation of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders[34533801]
Clin Exp HypertensProprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease[Pubmed:35502687]